Pre-Exposure Prophylaxis of HIV-1 Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pre-Exposure Prophylaxis of HIV-1 Infection trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pre-Exposure Prophylaxis of HIV-1 Infection trials you may qualify forResearchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking…
Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking…
Despite significant advances in HIV treatment, transmission remains a public health concern. In 2022, there were 1.3 million new HIV infections worldwide and 1,…
This is a pilot study to assess the feasibility, acceptability, and preliminary effectiveness of pre-exposure prophylaxis (PrEP)smart among cisgender sexual min…
The primary objective of this study is to assess the rates of HIV-1 infection in Men (MSM) and transgender women (TGW) who have sex with men and who are adminis…
This is an open-label phase 1b clinical trial enrolling people living with HIV (PLWH) who are antiretroviral therapy (ART)-naïve or have not been on ART for \>…